SLXN
Silexion Therapeutics Corp
Nasdaq Biological Products, (No Diagnostic Substances)
Emerging growth company

Key Financials

Net Income
$-11912000
↑ 27.9%
Operating Income
$-11632000
↑ 7.5%
Total Liabilities
$4.6M
↓ 32.7%
Total Assets
$7.2M
↑ 152.0%
Shareholders' Equity
$2.6M
↑ 165.3%
EPS (Diluted)
$8.96
↓ 66.0%
Cash & Equivalents
$6.0M
↑ 404.7%
Operating Cash Flow
$-10819000.00
↓ 28.9%

Recent SEC Filings

Form Type Filed Date Link
10-K/A 5/19/2026 View on SEC
8-K 5/18/2026 View on SEC
10-Q 5/15/2026 View on SEC
8-K 5/15/2026 View on SEC
SCHEDULE 13G/A 5/15/2026 View on SEC
8-K 5/14/2026 View on SEC
8-K 5/13/2026 View on SEC
EFFECT 5/11/2026 View on SEC
EFFECT 5/11/2026 View on SEC
POS AM 5/7/2026 View on SEC

Company Information

Field Value
Ticker SLXN
Company Name Silexion Therapeutics Corp
CIK 2022416
Sector Biological Products, (No Diagnostic Substances)
Industry
Emerging growth company
Exchange Nasdaq
SIC Code 2836
SIC Description Biological Products, (No Diagnostic Substances)
Entity Type operating
Fiscal Year End 1231
State of Incorporation E9
Phone 972-8-6286005